Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
An open, observational health economic study to estimate marginal cost and health
consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa
administered continuously